Last reviewed · How we verify
Corifollitropin alfa and menotropin
Corifollitropin alfa and menotropin is a Small molecule drug developed by D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology. It is currently FDA-approved. Also known as: Elonva, Merional.
At a glance
| Generic name | Corifollitropin alfa and menotropin |
|---|---|
| Also known as | Elonva, Merional |
| Sponsor | D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Continuous Double Ovarian Stimulation. (PHASE4)
- Type of Gonadotropin and Embryo Kinetics of Development (PHASE4)
- An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data
- Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG (PHASE4)
- Corifollitropin Alpha and Ovarian Response (NA)
- Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders (PHASE4)
- Second Step Protocol in Poor Ovarian Responder (POR)
- Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response. (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Corifollitropin alfa and menotropin CI brief — competitive landscape report
- Corifollitropin alfa and menotropin updates RSS · CI watch RSS
- D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology portfolio CI
Frequently asked questions about Corifollitropin alfa and menotropin
What is Corifollitropin alfa and menotropin?
Corifollitropin alfa and menotropin is a Small molecule drug developed by D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology.
Who makes Corifollitropin alfa and menotropin?
Corifollitropin alfa and menotropin is developed and marketed by D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology (see full D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology pipeline at /company/d-o-ott-research-institute-of-obstetrics-gynecology-and-reproductology).
Is Corifollitropin alfa and menotropin also known as anything else?
Corifollitropin alfa and menotropin is also known as Elonva, Merional.
What development phase is Corifollitropin alfa and menotropin in?
Corifollitropin alfa and menotropin is FDA-approved (marketed).
Related
- Manufacturer: D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology — full pipeline
- Also known as: Elonva, Merional
- Compare: Corifollitropin alfa and menotropin vs similar drugs
- Pricing: Corifollitropin alfa and menotropin cost, discount & access